GALECTIN THERAPEUTICS INC (GALT:NASDAQ)
$2.97 -0.26 (-8.0495%)
Analysed GALECTIN THERAPEUTICS INC (GALT:NASDAQ) News Sources
Galectin Therapeutics Highlights Belapectin Data in MASH Cirrhosis KOL Event, Eyes Next Steps
17-03-2026
marketbeat.com
Galectin Therapeutics Strengthens Board of Directors with Appointment of Henry Brem, M.D.
17-03-2026
yahoo.com
Galectin Therapeutics Reports 2025 Financial Results and Provides Business Update
31-03-2026
yahoo.com
Galectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?
03-04-2026
yahoo.com
Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology
11-05-2026
yahoo.com
Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update
15-05-2026
yahoo.com
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
27-05-2026
yahoo.com
Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
23-06-2026
yahoo.com
GALT Stock Surges 22% — On Track For Best Day In Over A Year After FDA Clears Path For Late-Stage Belapectin Trial
23-06-2026
stocktwits.com
GALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASH
24-06-2026
yahoo.com
What is the current price of GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The current price of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is $2.97.
GALECTIN THERAPEUTICS INC (GALT:NASDAQ) absolute price change since previous trading day?
The absolute price change of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) since the previous trading day is $-0.26.
GALECTIN THERAPEUTICS INC (GALT:NASDAQ) percentage price change since previous trading day?
The percentage price change of GALECTIN THERAPEUTICS INC (GALT:NASDAQ) since the previous trading day is -8.0495%.
What is the most recent average sentiment score for GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The most recent average sentiment score for GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for GALECTIN THERAPEUTICS INC (GALT:NASDAQ)?
The most recent sentiment for GALECTIN THERAPEUTICS INC (GALT:NASDAQ) is .
SEC-8K** Filing Available For GALECTIN THERAPEUTICS INC (GALT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.